Jane Street
ECYT

Jane Street’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Jane Street’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-11,100
Closed -$153K – 6072
2018
Q2 		$153K Sell
11,100
-3,700
-25% -$43.9K ﹤0.01% 4650
2018
Q1 		$135K Buy
+14,800
New +$81.7K ﹤0.01% 4546

Other funds holding ECYT

OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Jane Street's ECYT Position: Q4 2018 in Review

Jane Street sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 26,924 shares — an estimated $478K sold.

Jane Street first reported a position in ECYT in Q1 2014 and held it in 3 quarters. The position peaked at $910K in Q1 2014. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

  • Jane Street reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Jane Street sold 26,924 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $478K.
  • Jane Street first reported a position in Endocyte, Inc. Common Stock in Q1 2014 and held it in 3 quarters.
  • Jane Street's Endocyte, Inc. Common Stock position peaked at $910K in Q1 2014.
  • 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Jane Street's 13F filing for Q4 2018, filed 15 Feb 2019.